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Introduction1
The many pathogens that infect humans (e.g., viruses, bacteria, protozoa, fungal par-2
asites, helminths) often co-occur within individuals.1–5 Helminth coinfections alone are3
thought to occur in over 800 million people,6 and are especially prevalent among the4
global poor.7–9 Other coinfections involve globally important diseases such as HIV,10 tu-5
berculosis,11 malaria,12 hepatitis,13 leishmaniasis,14 and dengue fever.15 It seems likely,6
therefore, that the true prevalence of coinfection exceeds one sixth of the global population7
and often involves infectious diseases of pressing human concern.8
Improved understanding of coinfection prevalence is greatly needed,16 partly because coin-9
fecting pathogens can interact either directly with one another or indirectly via the host’s10
resources or immune system.3 Compared to infections of single pathogen species, these11
interactions within coinfected hosts can alter the transmission, clinical progression and12
control of multiple infectious diseases.17–19 Establishing the nature and consequences of13
coinfection requires integrated monitoring and research of different infectious diseases,114
but such data are rare.9,20,2115
Reviews of coinfection have emphasised that coinfection requires further research, espe-16
cially in humans,2,3,20,22 where coinfection outnumbers single infection in many commu-17
nities2,23 and where helminth coinfections appear to worsen human health.20 Coinfection18
involves a range of pathogens and can have various effects on coinfected hosts.3 There are19
many individual studies concerning coinfection, but these use various approaches and are20
often narrowly focused. We aimed to gain a coherent picture of the nature and conse-21
quences of coinfection in humans. We surveyed the published literature for the occurrence22
of coinfecting pathogens and their effects on other infecting organisms and human health.23
We found that coinfections involve a huge variety of pathogens, and most studies report24
negative effects on human health. However, current coinfection research rarely focuses on25
pathogens with highest global mortality.26
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Materials and Methods27
Literature search28
We searched the published literature for studies of coinfection (i.e. multi-species in-29
fections) in humans using the Advanced Search facility on the largest online citation30
database, Scopus (Elsevier Ltd.). Many disciplines study infectious diseases and various31
terms are used to describe coinfection. We therefore searched for co*infection, concomi-32
tant infection, multiple infection, concurrent infection, simultaneous infection, double33
infection, polymicrobial, polyparasitism, or multiple parasitism in the Title, Abstract,34
or Keywords of publications in the Life and Health Sciences before 2010. In June 201135
this search returned 12963 results; an equivalent search on an alternative online cita-36
tion database, Web of Science [Thomson Reuters], yielded similar trends in publications37
through time, but fewer results. Due to the large number of publications matching the38
search terms, we chose to focus on publications from 2009. Furthermore, publications39
concerning nonhuman hosts, non-infectious diseases or multiple genotypes of only one40
pathogen species were excluded.41
For each publication we collected data on the identity of coinfecting pathogens, journal,42
study type and maximum number of pathogen species found per person. Study types43
included experiments treating each infection, observational studies, and reviews/meta-44
analyses. Observational studies were either case notes on particular patients, studies of45
patient groups, or epidemiological surveys among human communities.46
Many publications reported the stated effect of one pathogen on the abundance of coin-47
fecting pathogens (i.e. proxies for the intensity of infection, e.g. from measures of viral48
load, faecal egg counts, antibody response, bacterial cultures etc.) and/or host health49
(e.g. survival, recovery time, anaemia, liver fibrosis, immune cell counts). These effects of50
coinfection are relative to conditions observed under infections of single pathogen species.51
Where these effects were reported we recorded the pair of coinfecting pathogens involved,52
the quality of measurement (rated as low [e.g. anecdotal], adequate [e.g. correlation] and53
high [i.e. full reporting of appropriate statistical test supported by theoretical mecha-54
nisms]) and other data (see below). Data from review-type publications, case notes and55
from publications not mentioning the effects of coinfection (120 publications for pathogen56
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abundance and 110 for host health) were excluded to avoid double counting, undue in-57
fluence of individual cases and the inclusion of irrelevant publications. Reported effects58
based on low quality evidence (10 publications for pathogen abundance and 24 for host59
health) were also omitted.60
Analyses of the effects of coinfection61
There was considerable heterogeneity in the reporting of the effects of coinfection, both in62
terms of the response variable and in terms of the quantitative measure given (e.g. odds63
ratios, adjusted odds ratios, P -values, hazards ratios, raw comparisons). Furthermore,64
many publications gave qualitative statements of effect direction. Among publications65
quantifying effect size, diverse measures were given across publications. We focused on66
the direction of reported effects (positive, negative and no-effect) to maximise the data67
available. Reported directions of the effects on both pathogen abundance and host health68
for each pair of coinfecting pathogens was coded +1 for positive effect, 0 for neutral,69
−1 for negative effects, and NA if no information about effect direction was given. The70
resulting dataset includes some repeated measures because some publications reported71
multiple pairs of coinfecting pathogens and some coinfections were reported in multiple72
publications. We created two independent datasets containing the mean effect direction (i)73
per publication and (ii) per coinfection to eliminate these sources of pseudoreplication. A74
negative mean implied a predominance of negative effects; a positive mean implied a dom-75
inance of positive effects. A mean close to 0 could result from either many neutral effects76
(whereby a pathogen consistently had no discernible effect) and/or equal numbers of pos-77
itive and negative effects (whereby a pathogen had different, possibly context-dependent78
effects). In either case, there is no clear indication of these pathogens having a consistent79
effect on each other (or on host health), so we adopt the most conservative interpretation80
and assume there is no effect. These means were converted into three categories: negative81
(−1 to − 1
3
), neutral (−1
3
to + 1
3
) and positive (+1
3
to + 1). Chi-squared tests24 based82
on double log-likelihood values25,26 were done to establish whether totals in each category83
differed from those expected from two different null hypotheses (random and no-effect).84
The random null model was of equal proportions of positive, neutral and negative effects,85
while the no-effect null model was that coinfecting pathogens do not interact, allowing for86
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a 5% error rate (hence 2.5% negative, 2.5% positive, and 95% neutral reported effects).87
This constitutes a recommended vote-counting method deriving continuous parameters88
analysed against confidence intervals (α = 0.05).2789
Finally, we explored the potential influence of the missing data (NAs) on the effects90
of coinfection in the analysis (56 for pathogen abundance, 79 for host health). These91
values represent reported coinfections where the effect on either pathogen abundance or92
host health was not reported, despite the possibility that these coinfecting pathogens93
did interact with each other and/or influence host health. We therefore assessed how94
potential interactions from these unreported effects may alter the overall patterns of95
coinfection effects. To determine their potential impact on the estimated overall effects,96
NAs were assigned one of three values at random (+1, 0,−1). The mean effect was then97
calculated per publication or coinfection pair as before, and a grand mean taken across all98
publications or coinfection-pairs. The grand mean represents an estimate of overall effect99
of coinfection on either host health or pathogen abundance across either publications or100
coinfections, given a particular random assignment of −1, 0,+1 to NAs. Repeating this101
random assignment 1000 times produced a distribution of grand means.102
Comparison with WHO data103
We examined whether recent coinfection research focuses on the pathogens causing the104
highest global mortality. We obtained global totals for the number of deaths (both sexes,105
all ages) in 2009 under every category of infection collated by the World Health Or-106
ganisation (obtained from the Global Burden of Disease section of the Global Health107
Observatory website)28. We compared the ten categories causing most global deaths in108
2009 with total reports of coinfection involving these infections. Comparing the top ten109
infection categories by mortality with their morbidity measures (DALYs) yielded similar110
trends, so we present only data from the mortality comparison.111
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Results112
Overall trends in coinfection publications113
Hundreds of publications on coinfection are published annually and have increased from114
219 publications in the first year of search results to 1464 publications in 2009 (Fig. 1).115
This increase includes studies of both human and non-human hosts. Of the 1464 pub-116
lications retrieved for 2009, 309 reported multiple pathogen species coinfecting humans.117
Publications came from 192 journals, with most (136 of 192 journals, 70.8%) publishing118
a single coinfection article in 2009.119
The majority of relevant publications from 2009 were observational studies (234 of 309,120
75.0%), of which 159 (67.9%) involved patient groups, 60 (25.6%) were case notes and 18121
(7.7%) surveyed a population. Three observational studies (1.3%) analysed death records.122
Seventy publications (22.4%) were reviews or metaanalyses. Five publications (1.6%) were123
experimental, whereby treatment and controls were applied to both singly infected and124
coinfected groups. A majority of the relevant publications concerned coinfections by two125
pathogen species (249 of 309, 80.5%), but more pathogen species per individual were126
occasionally reported; the mean number of pathogens was 2.4 and a maximum of 13127
pathogens was reported twice in a venous leg ulcer29 and a periodontal infection30.128
Reported coinfecting pathogens129
A total of 270 pathogen taxa were reported in coinfection publications from 2009, across130
1265 reports of coinfections comprising 933 different pairs of coinfecting pathogen taxa.131
All pathogen types (viruses, bacteria, protozoa, fungal parasites, helminths) were reported132
in coinfections; the most common pathogen group were bacteria (Table 1). In terms of133
specific pairs of reported coinfecting pathogens there was high diversity, but HIV and134
hepatitis viruses featured relatively highly (Table 1).135
Effects of coinfection on pathogen abundance and human health136
Effects of coinfection on pathogen abundance and host health were sampled across 173137
suitable publications according to pathogen abundance and host health. These publica-138
tions covered 827 coinfecting pairs of pathogens, involving 183 pathogen species. Among139
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these coinfections, 203 (24.5%) measured the size or direction of effects on pathogen140
abundance and 191 (23.1%) measured the size or direction of effects on host health. The141
remainder of coinfections had no reports of the effects of coinfection in suitable publica-142
tions.143
Overall, positive effects of coinfection on pathogen abundance were the most common144
reported across publications (6 negative, 15 neutral, 28 positive reports across 49 publi-145
cations; Fig. 2A). Among specific pairs of coinfecting pathogens neutral effects exceeded146
positive effects (10 negative, 95 neutral, 69 positive across 174 unique pathogen pairs;147
Fig. 2C). In both cases these patterns were strongly significantly different from both the148
random null model (grey line on Fig. 2, by publication [X2 = 15.6, d.f. = 2, P < 0.001]149
and by coinfection [X2 = 82.6, d.f. = 2, P < 0.001]) and from the no-effect null model150
(black line on Fig. 2, by publication [X2 = 160.3, d.f. = 2, P < 0.001] and by coinfection151
[X2 = 292.8, d.f. = 2, P < 0.001]).152
Regarding the impact of coinfection on host health, there was a much greater number153
of negative effects reported in publications than either positive, neutral or NA categories154
(51 negative, 12 neutral, 4 positive across 67 publications; Fig. 2B). When data were155
aggregated by specific pathogen pairs the neutral effects exceed the negative effects (51156
negative, 84 neutral, 5 positive across 140 unique pathogen pairs; Fig. 2D). In both cases157
these patterns were significantly different from both the random null model (grey line,158
by publication [X2 = 55.6, d.f. = 2, P < 0.001, Fig. 2B] and by coinfection [X2 =159
85.5, d.f. = 2, P < 0.001, Fig. 2D]) and from the no-effect null model (black line,160
by publication [X2 = 315.4, d.f. = 2, P < 0.001, Fig. 2A] and by coinfection [X2 =161
199.6, d.f. = 2, P < 0.001, Fig. 2C]).162
It is unlikely that these patterns of the effects of coinfection would be changed by knowl-163
edge of the unreported effects (the NAs in Fig. 2). Even after NA values were assigned164
predominantly to the neutral category (i.e. under the no-effect null model), the distribu-165
tion of the grand mean effect was positive for the effects on pathogen abundance (Fig. 3A166
and C), and negative for effects on host health (Fig. 3B and D). None of the distributions167
of grand means overlapped zero (Fig. 3).168
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Do coinfection studies focus on the most important infectious diseases?169
We found notable differences between the most commonly reported coinfecting pathogens170
and the infections causing the greatest global health burden (Fig. 4). The largest infec-171
tious causes of mortality are respiratory infections, causing 44.7% of these deaths with the172
next greatest causes, diarrhoea and HIV/AIDS, causing half as many deaths. Other im-173
portant infections by global mortality are tuberculosis, malaria and childhood infections174
(measles, meningitis, whooping cough and tetanus). The tenth biggest infectious cause of175
mortality worldwide, HBV, is the only hepatitis virus featuring in the top ten infectious176
causes of mortality, causing 1.1% of infectious disease deaths. In comparison, hepatitis177
viruses featured in one fifth of reported coinfections (286 of 1265, 22.6%). The top ten178
pathogen species reported in coinfections were HIV (in 266 [21.9%] of 1265 coinfections),179
HCV (11.4%), HBV (7.04%), Staphylococcus aureus (4.58%), Escherichia coli (4.43%),180
Pseudomonas aeruginosa (3.72%), M. tuberculosis (5.9%), HPV (3.16%), unidentified181
Streptococcus spp. (3.00%), and unidentified Staphylococcus spp. (3.00%). Some of the182
most common reported coinfecting pathogens (HCV, Staphylococcus, HPV, and Strepto-183
coccus) contribute relatively little to global infection mortality. Perhaps surprisingly, four184
of the most important infectious causes of mortality (all of them childhood infections)185
received very few or no reports of coinfection in 2009 publications.186
Discussion187
Interest in coinfection has increased in recent years, with publications on human coin-188
fection involving hundreds of pathogen taxa across all major pathogen groups. Recent189
publications tend to show that negative effects of coinfection on human health are more190
frequent than no effect or positive effects. However, the most commonly reported coinfect-191
ing pathogens differ from those infections causing highest global mortality. These results192
raise questions concerning the occurrence and study of coinfection in humans and their193
implications for effective infectious disease management.194
The overall consequence of reported coinfections was poorer host health and enhanced195
pathogen abundance, compared with single infections. This is strongly supported by196
significant statistical differences in the reported direction of effects (P < 0.001) from ex-197
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pectations of either no-effect or of random distributions, and by the robustness of these198
trends in the face of missing values and by diversity in the types of publications in which199
these coinfections were reported. Moreover the tendency for positive effects on pathogen200
abundance corroborates the negative effects on host health because larger infections are201
a mechanism by which disease can be exacerbated. The consistency of these detrimental202
coinfection effects across a wide range of pathogens suggests a general incidence of inter-203
actions between coinfections. The long-term effects among survivors of coinfections can204
be varied and in some cases severe, including blindness, chronic diarrhoea, chronic inflam-205
mation, carcinoma, immunosuppression, liver fibrosis, meningitis, renal failure, rheumatic206
fever, etc.31.207
The direction of reported coinfection effects could have at least two explanations. The208
first is that coinfection may be more likely in individuals of poor health, which in turn209
leads to poorer prognosis among coinfected cases. The relative paucity of experimental210
studies of coinfection in humans means sampling biases towards people of poorer health211
is possible, but impossible to account for in our analyses. The second explanation is that212
coinfecting pathogens interact synergistically with each other, for example via the host’s213
immune system, so that the presence of one enhances the abundance and/or virulence of214
the other. A clear example of this is HIV, which causes immunosuppression, increasing215
the likelihood of additional infections and occurred in two fifths of reported coinfections216
(Fig. 4).217
Differences between reported coinfections and global mortality figures may also suggest218
important interactions between coinfecting pathogens. Coinfections that were more com-219
monly reported than their relative contribution to global mortality may involve particular220
synergistic pathogen-pathogen interactions, such as among herpes viruses like CMV or221
HSV infection enhancing the risk of HPV coinfection.32 Conversely, infections that cause222
high mortality but had relatively few reports of coinfection could result from antagonistic223
interactions, reducing the likelihood of such coinfections occurring and being reported, like224
Pseudomonas aeruginosa exoproduct limiting Staphylococcus aureus colony formation.33225
An alternative and possibly more likely explanation of the discrepancies between reported226
coinfections and global mortalities from infections could be greater funding availability227
(e.g. HIV/AIDS research), higher interests of virologists in coinfection and/or easier ob-228
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servations or more routine screening compared with other pathogens, for instance the229
greater difficulty of detecting intestinal helminths in coinfection research. The lack of230
coinfection publications reporting on major infectious causes of childhood mortality re-231
mains unexplained. While some publications do study childhood coinfection and find232
coinfection to be more common in children,34 current coinfection research does not in-233
clude the infections that kill the most infants globally. Fewer than 1 in 20 publications234
reported coinfections involving helminths, despite hundreds of millions of helminth coin-235
fections globally,6 which could arise from limited published research on helminthiases. To236
what extent disparities between global mortality data reflect actual epidemiology or biases237
in research attention remains to be established, in part hindered by current inadequacies238
in coinfection surveillance.239
The disparity between infections that feature highly in global mortality statistics and240
those receiving most attention in published coinfection studies poses a challenge to infec-241
tious disease research. A general understanding of the effects of coinfection is important242
for appropriate control of infectious diseases.4,7,8,35 Poor or uncertain observational data243
regarding coinfection hinders efforts to improve health strategies for infectious disease in244
at-risk populations.9 For example, global infectious disease mortality data28 report only245
single causes of death, even if comorbidities were identified. If health statistics better246
represent coinfection, published coinfection research could be better evaluated. Moreover247
there is a lack of coherence in coinfection literature, with a variety of synonyms being used248
for the same phenomenon, which is multi-species infection (see the Methods for exam-249
ples). The term polymicrobial, while commonplace, is restricted to coinfections involving250
microbes. Coinfection is a broader term encompassing all pathogen types including in-251
teractions between the same kinds of pathogens as well as cross-kingdom coinfections252
between, say, bacteria and helminths. Ultimately decisions over which term to prefer (if253
any) need to be made by a consensus of the diverse research communities concerned with254
this phenomenon. True patterns of coinfection remain unknown21 and our results suggest255
that it may be starkly different from existing data on important infectious diseases.256
Overall recently published reports of coinfection in humans show coinfection to be detri-257
mental to human health. Understanding the nature and consequences of coinfection is258
vital for accurate estimates of infectious disease burden. In particular, more holistic data259
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on infectious diseases would help to quantify the size of the effects on coinfection on260
human health. Improved knowledge of the factors controlling an individual’s risk of coin-261
fection, circumstances when coinfecting pathogens interact, and the mechanisms behind262
these pathogen-pathogen interactions, especially from experimental studies, will also aid263
the design and evaluation of infectious disease management programmes. To date, most264
disease control programs typically adopt a vertical approach to intervention, dealing with265
each pathogen infection in isolation. If coinfecting pathogens generally interact to worsen266
human health, as suggested here, control measures may need to be more integrated and267
specialist treatments developed for clinical cases of coinfection. Further research is needed268
to identify the role of predisposed risks to coinfection.269
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Tables and figures371
Table 1. Number of reports of each type of pathogen and the five most reported pair of372
coinfecting pathogens among 2009 coinfection publications.
Pathogen Type Frequency (%) Coinfecting pathogens Frequency (%)
Bacteria 1351 (53.4) HCV-HIV 82 (6.5)
Viruses 877 (34.7) HBV-HIV 31 (2.4)
Protozoa 117 (4.6) HBV-HCV 30 (2.4)
Helminths 78 (3.1) HIV-Mtb 28 (2.2)
Fungi 81 (3.2) HIV-HPV 27 (2.1)
HBV = Hepatitis B Virus, HCV = Hepatitis C Virus, HIV = Human Immunodeficiency
Virus, Mtb = Mycobacterium tuberculosis, HPV = Human Papillomavirus
373
The Nature and Consequences of Coinfection in Humans Journal of Infection 16
l
l
l
l
l
ll
l
l
ll
l
l
l
l
1996 1998 2000 2002 2004 2006 2008
5.
6
5.
8
6.
0
6.
2
6.
4
6.
6
6.
8
7.
0
Year
Se
ar
ch
 re
su
lts
 (lo
gg
ed
)
Figure 1: Annual coinfection publications (log10) from initial Scopus search. See the Methods section for
search criteria.
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Figure 2: Direction of reported effects of coinfection on the abundance of infecting pathogens and host
health averaged across publications and coinfections published in 2009. Horizontal lines indicate expected
values of null hypotheses (black=no-effect, grey=random).
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Figure 3: Distribution of grand mean effects of coinfection including simulations of missing values ac-
cording to the random (grey line) and no-effect (black line) null models. Lines generated by a Gaussian
kernel estimator (smoothing bandwidths: random = 5.1 × 10−3, no-effect = 1.2× 10−3).
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Figure 4: Top ten infections from global mortality data28 (grey bars), compared with percentage of times
the infections were reported in coinfections in 2009 publications (black bars).
